Nutra Pharma Corp (NPHC) Share-based Compensation (2010 - 2026)

Nutra Pharma has disclosed Share-based Compensation across 15 years of filings, most recently posting $2000.0 for Q2 2026.

• In Q2 2026, Share-based Compensation fell 80.0% year-over-year to $2000.0; the TTM figure through Jun 2026 stood at $39000.0 (up 290.0% YoY), while the FY2025 annual figure was $26667.0, changed N/A from the prior year.
• Share-based Compensation came in at $2000.0 for Q2 2026 at Nutra Pharma, down from $12000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $36000.0 in Q1 2022 to a low of $2000.0 in Q2 2026.
• Average Share-based Compensation over 3 years is $13218.8, with a median of $10375.0 recorded in 2022.
• Year-over-year, Share-based Compensation sank 98.29% in 2022 and plunged 80.0% in 2026.
• Over 3 years, Share-based Compensation stood at $10500.0 in 2022, then surged by 57.14% to $16500.0 in 2025, then tumbled by 87.88% to $2000.0 in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $2000.0 in Q2 2026, $12000.0 in Q1 2026, and $16500.0 in Q4 2025.